RC

Riccardo Canevari

Radiopharm Theranostics Limited | Chief Executive Officer, Managing Director
Mr.Canevari was previously Chief Commercial Officer of Novartis company, Advanced Accelerator Applications, from April 2020 to September2021, one of the radiopharmaceutical and nuclear medicine companies globally. He was responsible for commercial strategy and country organizations in approximately 20 countries across North America, Europe and Asia. Prior to that, he was Senior Vice President and Global Head of the Breast Cancer Franchise for Novartis Oncology from 2017, where he oversaw the launch of breast cancer products. Mr. Canevari has also held management roles with Novartis Pharma and Ethicon/Johnson & Johnson.

Company and Roles

Company
Title
Tenure
Since
RAD
RAD
Radiopharm Theranostics Limited
  • Chief Executive Officer
  • Managing Director
3yrs, 2mthSep 2021

Holding

Company
Last Notice
Direct Shares
Indirect Shares
Options
Convertibles
RAD
RAD
Radiopharm Theranostics Limited
13/09/2412,253,5841,150,00055,699,013N/A

Transactions

Company
Date
Type
Amount
Price
Value
Notes
RAD
RAD
Radiopharm Theranostics Limited
13/09/24
Issued
3,750,000$0.040$150,000Placement
RAD
RAD
Radiopharm Theranostics Limited
13/09/24
Issued
25,875,000$0.030$776,250Placement
RAD
RAD
Radiopharm Theranostics Limited
14/12/23
Issued
2,128,815$0.105$223,525Issue of securities
RAD
RAD
Radiopharm Theranostics Limited
08/12/23
Issued
800,000$0.070$56,000Rights issue
RAD
RAD
Radiopharm Theranostics Limited
01/12/23
Issued
7,426,895$0.074$549,590Issue of options